search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Determinants of adherence to diabetes medication


- candidate number23554
- NTR NumberNTR5516
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR4-jan-2016
- Secondary IDs15-4-181 15-N-209
- Public TitleDeterminants of adherence to diabetes medication
- Scientific TitleWhich socio cognitive determinants explain why some people do, and some people don't adhere to their diabetes medication regime?
- ACRONYMN.V.T
- hypothesisN.V.T
- Healt Condition(s) or Problem(s) studiedDiabetes Mellitus, Insuline, Medication adherence
- Inclusion criteriaType 2 diabetes, aged between 40-70 years old, using at least one antidiabetic agent, being treated in the Netherlands for diabetes, being diagnosed for at least 1 year with type 2 diabetes
- Exclusion criteriaNot able to speak or understand the dutch language
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- group[default]
- Type[default]
- Studytypeobservational
- planned startdate 1-jan-2016
- planned closingdate1-jan-2017
- Target number of participants550
- Interventionsn.v.t.
- Primary outcomeAdherence to diabetes medication (divided into oral agent adherence and insulin adherence)
- Secondary outcomeDeterminants of medication adherence
- TimepointsBaseline measurement (01012016 - 0104-2016)
Follow-up measurement (0106-2016 - 01102016)
- Trial web sitenvt
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES Stan Vluggen
- CONTACT for SCIENTIFIC QUERIES Stan Vluggen
- Sponsor/Initiator Maastricht University Medical Center (MUMC+), ZIO (Zorg in ontwikkeling), Zuyderland Medical Center, Heerlen
- Funding
(Source(s) of Monetary or Material Support)
Maastricht University Medical Center (MUMC+)
- Publications
- Brief summaryA survey study which aims to identify determinants of adherence to diabetes medication, divided into oral agents and insulin. At 6 months, a follow-up questionnaire will be spread among initial participants, to identify predictors of adherence over time.
- Main changes (audit trail)
- RECORD4-jan-2016 - 15-jan-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl